Hypoxanthine,
a purine derivative, is one of the doping components
of biogenic guanine crystals and can form cocrystals with guanine
in organisms. As far as we know, there is no research work related
to the controlled formation of anhydrous hypoxanthine (AH) crystals,
neither the relationship of the morphology nor the optical properties
of hypoxanthine crystals. Herein, the controlled synthesis of square
AH nanoplatelets is realized for the first time in aqueous solution
in the presence of poly(N-vinylcaprolactam). The
lattice parameters of synthetic hypoxanthine crystals are simulated
based on experimental powder X-ray diffraction and selected area electron
diffraction data, which are proposed to be AH with monoclinic symmetry.
The length and thickness of AH nanoplatelets are about 1–3
μm and 65 ± 5 nm, respectively. Poly(N-vinylcaprolactam) and Soluplus, both containing caprolactam groups,
can preferentially adsorb on and stabilize the (100) plane of AH crystals.
The AH nanoplatelets are composed of hypoxanthine molecules with inner-layer
hydrogen bonding networks and interlayer π–π stacking.
Square-shaped single-crystalline AH nanoplatelets with monoclinic
symmetry are proposed to be formed via the transformation of intermediate
amorphous hypoxanthine nanoparticles. The AH nanoplatelets exhibit
excellent optical properties including high reflectivity, depolarization,
and brilliant pearlescent luster.